IHC analyses determined that both peroxidasin and ADAMTS16 were enriched in tumour cell-rich regions of lung tumour tissue, although IHC scoring of either of these candidates did not represent a significant predictor of survival in the TMA cohort of NSCLC patients. The gene discussed is ADAMTS16; the disease is non-small cell lung carcinoma.